Healthcare & Medical Investment (TSE:3455) Net Margin %: 40.20% (As of Jan. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3455 Healthcare & Medical Investment Corp TSE:3455
59 GF Score
Price 円105,400.00
GF Value 円129,254.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Healthcare & Medical Investment Net Margin %?

Healthcare & Medical Investment TSE:3455 -2.04% 59 Net Margin % is 40.20% as of Jan. 2026, which is 7% below its 10-year median of 43.41. GuruFocus rates TSE:3455 with a GF Score™ of 59/100 and a GF Value™ of 円129,254.71 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 917 REITs companies, Healthcare & Medical Investment ranks worse than 56.05% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Healthcare & Medical Investment's Net Income for the six months ended in Jan. 2026 was 円1,058 Mil. Healthcare & Medical Investment's Revenue for the six months ended in Jan. 2026 was 円2,631 Mil. Therefore, Healthcare & Medical Investment's net margin for the quarter that ended in Jan. 2026 was 40.20%.

The historical rank and industry rank for Healthcare & Medical Investment's Net Margin % or its related term are showing as below:

TSE:3455' s Net Margin % Range Over the Past 10 Years
Min: 40.08   Med: 43.41   Max: 47.91
Current: 40.08


TSE:3455's Net Margin % is ranked worse than
56.05% of 917 companies
in the REITs industry
Industry Median: 45.43 vs TSE:3455: 40.08

Healthcare & Medical Investment  (TSE:3455) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Healthcare & Medical Investment Net Margin % Related Terms


Healthcare & Medical Investment Net Margin % Historical Data

* Premium members only.

The historical data trend for Healthcare & Medical Investment's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare & Medical Investment Net Margin % Chart

Healthcare & Medical Investment Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.33 45.22 46.27 42.49 40.30

Healthcare & Medical Investment Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.04 41.95 40.64 39.97 40.20

TSE:3455 vs WELL, VTR, OHI: Net Margin % Comparison

For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthcare & Medical Investment Net Margin % vs REITs Industry

For the REITs industry and Real Estate sector, Healthcare & Medical Investment's Net Margin % distribution charts can be found below:

* The bar in red indicates where Healthcare & Medical Investment's Net Margin % falls into.


TSE:3455
59GF Score
Healthcare & Medical Investment Corp TSE:3455
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthcare & Medical Investment Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Healthcare & Medical Investment's Net Margin for the fiscal year that ended in Jul. 2025 is calculated as

Net Margin=Net Income (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=2041.638/5065.995
=40.30 %

Healthcare & Medical Investment's Net Margin for the quarter that ended in Jan. 2026 is calculated as

Net Margin=Net Income (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=1057.668/2631.19
=40.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 40.20% mean?
Healthcare & Medical Investment (TSE:3455) has a Net Margin % of 40.20% as of Jan. 2026. Net margin is the ratio of total net income to net sales. View historical data on Healthcare & Medical Investment and its competitors. This is near median its historical median of 43.41. Over the past decade, Healthcare & Medical Investment's Net Margin % has ranged from 40.08 to 47.91. According to the industry distribution chart, Healthcare & Medical Investment ranks #514 out of 917 companies in the REITs industry, placing it in the top 56.1%.
Is Healthcare & Medical Investment's Net Margin % too high?
Healthcare & Medical Investment's current Net Margin % of 40.20% is near median its 10-year median of 43.41. Over the past 10 years, this metric has ranged from a low of 40.08 to a high of 47.91. The REITs industry median Net Margin % is 45.43. Healthcare & Medical Investment's value of 40.20% is 11.5% below this industry median. Based on the distribution chart, Healthcare & Medical Investment ranks #514 out of 917 companies in the REITs industry, which is below the industry midpoint. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's Net Margin % compare to WELL and VTR?
According to the REITs industry distribution chart, Healthcare & Medical Investment ranks #514 out of 917 companies for Net Margin %. This places Healthcare & Medical Investment in the lower half of its industry. The industry median Net Margin % is 45.43. Healthcare & Medical Investment's value of 40.20% is 11.5% below this benchmark. Historically, Healthcare & Medical Investment's own Net Margin % has ranged from 40.08 to 47.91 over the past decade. While the company's 10-year median is 43.41 vs. the industry median of 45.43, Healthcare & Medical Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a REITs company?
The median Net Margin % among REITs companies is 45.43, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current Net Margin % of 40.20% is 11.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Healthcare & Medical Investment and its competitors. For the REITs industry, the median Net Margin % is 45.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current Net Margin % is 40.20%, which is near median its own 10-year median of 43.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current Net Margin % is 40.20%, which is near median its 10-year median of 43.41 and 11.5% below the REITs industry median of 45.43. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current Net Margin % is 40.20% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?

Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued. The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71. GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.

Key valuation signals for TSE:3455:

  • Net Margin %: 40.20% (near median its 10-year median of 43.41)
  • GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs
  • Industry Position: 11.5% below the REITs median (#514 of 917)

No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healthcare & Medical Investment Business Description

Industry Real EstateREITs
Address 3-3, Kanda-ogawamachi, Chiyoda-ku, Tokyo, JPN
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score

Get the complete analysis for TSE:3455

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円105,400.00
Price
円129,254.71
GF Value